HR Execs on the Move


 
Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of high-quality, innovative cannabis products sold under its trusted portfolio of consumer brands, Verano™, MÜV™, Savvy™, BITS™, Encore™, and Avexia™. Verano`s portfolio encompasses 14 U.S. states, with active operations in 13, including 14 production facilities comprising over 1,000,000 square feet of cultivation capacity. Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf™ and MÜV™, ...
  • Number of Employees: 5K-10K
  • Annual Revenue: $500M-1 Billion
  • www.verano.com
  • 415 North Dearborn Street 4th Floor
    Chicago, IL USA 60654
  • Phone: 312.265.0730

Executives

Name Title Contact Details
Oliver Munoz
Director, Talent Acquisition Profile
Dana Bisconti
Director, Finance Regional Profile
David Spreckman
Chief Marketing Officer Profile
Neil Byerle
Vice President of Sales (Wholesale) Profile
Destiny Thompson
Chief People Officer Profile

Similar Companies

Midtown Community Health Center

Midtown Community Health Center is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Ogden, UT. To find more information about Midtown Community Health Center, please visit www.midtownchc.org

Advanced Imaging Technologies

Advanced Imaging Technologies is a Richland, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Timicoin

The most reliable, completely - decentralized, health information exchange is waiting for you.

New Mexico Cancer Center

New Mexico Cancer Center is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Xenon Pharmateuticals

Xenon Pharmaceuticals (NASDAQ:XENE) – a biopharmaceutical company with operations in Vancouver, BC, Canada and Boston, MA, U.S.A. – is committed to delivering innovative medicines to provide a brighter future for patients suffering from neurological disorders. At Xenon, we are advancing an exciting pipeline of neurology-focused therapies, with a particular emphasis on novel treatments for both adult and pediatric patients with epilepsy. XEN496 is currently being evaluated in the Phase 3 “EPIK” clinical trial in young patients with KCNQ2-DEE, a rare and severe form of childhood epilepsy. Late-stage development plans are also underway for our XEN1101 program, building upon the compelling data from the Phase 2b “X-TOLE” study in adult patients with focal epilepsy. We are also proud of the leading-edge science coming out of our discovery labs, with many early-stage research programs underway. In addition to Xenon`s proprietary programs, we have ongoing collaborations with our valued pharmaceutical partners. With a healthy balance sheet to support our growth plans, we continue to build a fully-integrated, premier neuroscience company with strong discovery, development, and commercial operations. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver new medicines for patients in need. Building and maintaining a respectful, collaborative, inclusive, and productive culture is a priority for us. We are looking for great people who thrive in a fast-paced, dynamic work environment to join our team during this transformative time for Xenon.